Particle-Mediated Gene Delivery System for Cancer Research

Concepts in Gene Therapy

Volumn , Issue , 2020, Pages 109-120

  Rakhmilevich, Alexander L ^a   Yang, Ning Sun ^a  

^a University of Wisconsin Medical Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85134288050     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1515/9783110808636-008     Document Type: Chapter

References (56)

1. Yang, N.S. and Sun, W. (1995). Gene Gun and Other Non-viral Approaches for Cancer Gene Therapy. Nature Med. 1, 481-483.
2. Yang, N.S., Sun, W. H., and McCabe, D. (1996). Developing particle-mediated gene-transfer technology for research into gene therapy. Mol. Med. Today 2, 476-481.
3. Kolitz, J. and Mertelsmann, R. (1991). The Immunology of Human Cancer with Interleukin 2: Present Status and Future Directions. Cancer Investigation 9, 529-542.
4. Maas, R., Dullens, H., and Otter, W. D. (1993). Interleukin-2 in cancer treatment: disappointing or (still) promising? A review. Cancer Immunol Immunother 36, 141-148.
5. Lotze, M., Matory, Y., Rayner, A. et al. (1986). Clinical Effects and Toxicity of Interleukin-2 in Patients with Cancer. Cancer 58, 2764.
6. Marshall, E. (1995). Cancer Trial of Interleukin-12 Halted. Science 268, 1555.
7. Gansbacher, B., Zier, K., Daniels, B., Cronin, K., Bannerji, R., and Gilboa, E. (1990). Interleukin 2 Gene Transfer into Tumor Cells Abrogates Tumorigenicity and Induces Protective Immunity. J Exp. Med. 172, 1217-1224.
8. Golumbek, P., Lazenby, A., Levitsky, H., et al. (1991). Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4. Science 254, 713-716.
9. Heaton, K.M. and Grimm, E.A. (1993). Cytokine combinations in immunotherapy for solid tumors: a review. Cancer Immunol. Immunotherapy 37, 213-219.
10. Pardoll, D. (1992). New strategies for active immunotherapy with genetically engineered tumor cells. Current Opinion in Immunol. 4, 619-623.
11. Colombo, M.P., Modesti, A., Parmiani, G., and Forni, G. (1992). Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res. 52, 4853-4857.
12. Colombo, M. and Forni, G. (1994). Cytokine Gene Transfer in Tumor Inhibition and Tumor Therapy: Where are we now? Immunology Today 15, 48-51.
13. Rosenberg, S. A. (1992). Immunization of cancer patients using autologous cancer cells modified by insertion of the gene interleukin-2 (IL-2). Human Gene Therapy, 3, 167-177.
14. Cassileth, P. A. and Podack, E. (1995). Phase I study of transfected cancer cells expressing the interleukin-2 gene product in limited stage small cell lung cancer. Human Gene Therapy, 6, 369-383.
15. Stingl, G. (1996). Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Human Gene Therapy, 7, 551-563.
16. Rosenberg, S. A. (1990). Gene therapy of patients with advanced cancer using tumor-infiltrating lymphocytes transduced with the gene coding for tumor necrosis factor. Human Gene Therapy, 1, 441-480.
17. Rosenberg, S. A., Aebersold, P., Cornetta, K., Kasid, A., Margan, R. A., Moen, R. A., Karson, E. M., Lotze, M. T., Yang, J. C., Topalian, S. L., Merino, M. J., Culver, K., Miller, A. D., Blaese, R. M., and Anderson, W. F. (1990). Gene transfer into humans - immunotherapy of patients with advanced melanoma using tumor infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med., 323, 570-578.
18. Toso, J. F., Oei, C., Oshidari, F., Tartaglia, J., Paoletti, E., Lyerly, H. K., Talib, S., and Weinhold, K. J. (1996). MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation. Cancer Res. 56, 16-20.
19. Noguchi, Y., Chen, Y.N., and Old, L. (1994). A Mouse Mutant p53 Product Recognized by CD4+ and CD8+ T cells. Proc. Natl. Acad. Sci. USA 91, 3171-3175.
20. Tiberghien, P. (1994). Use of Suicide Genes in Gene Therapy. J. Leukocyte Biology 56, 203-209.
21. Plautz, G.E., Yang, Z.Y., Wu, B.Y, Gao, X., Huang, L., and Nabel, G.J. (1993). Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. USA 90, 4645-4649.
22. Chen, L., Linsey, P., and Hellström, K.E. (1993). Costimulation of T cells for tumor immunity. Immunol. Today 14, 483-486.
23. Touchette, N. (1996). Not ready for prime time. Nature Medicine 2, 7-8.
24. Kreeger, K. Y. (1996). Gene therapy trials should be driven by basic science. The Scientist 22, 10-12.
25. Marshall, E. (1996). Less hype, more biology needed for gene therapy. Science 270, 1751.
26. Woffendin, C., Yang, Z. Y., Udaykumar, Yang, N. S., Sheehy, M., and Nabel, G. (1994). Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc. Natl. Acad. Sci. U.S.A. 91, 11581, 11585.
27. Fox, B., Woffendin, C., Yang, Z. Y. San, Hong, Ranga, U., Gordon, D., Osterholzer, J., and Nabel, G. (1995). Genetic Modification of Human Peripheral Blood Lymphocytes with a Transdominant Negative Form of Rev: Safety and Toxicity. Human Gene Therapy 6, 997-1004.
28. Miller, D. G., Adam, M. A., and Miller, A. D. (1990). Gene transfer by retrovirus vector occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10, 4239-4242.
29. Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L.E., Paakko, P. K., Giraldi, P., Stratford-Perricaudet, L. D., Perricaudet, M., Jallat, S., Pavirani, A., Iecocq, J., and Crystal, R. G. (1991). Adenovirus-mediated transfer of recombinant alpha-1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.
30. Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L.E., Stratford-Perricaudet, L. D., Perricaudet, M., Guggino, W. B., Pavirani, A., Iecocq, J. P., and Crystal, R. G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
31. Chen, S-H., Shine, H. D., Goodman, J. C., Grossman, R.G., and Woo, S.L.C. (1994). Gene therapy for brain tumors: Regression of experimental brain tumors by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91, 3054-3057.
32. Cotten, M. Wagner., E., Zatloukal, K., Phillips, S., Curiel, D., and Birnstiel, M.L. (1992). Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected cells. Proc. Natl. Acad. Sci. USA 89, 6094-6098.
33. Gao, L., Wagner, E., Cotten, M., Agarwal, S., Harris, C., Rømer, M., Miller, L., Hu, P.C., and Curiel, D. (1993). Direct gene transfer into airway epithelium employing adenovirus-polysine-DNA complexes. Human Gene Therapy 4, 17-24.
34. Yang, Y., Nunes, F. A., Berencsi, K., Furth, E.E., Gonczol, E., and Wilson, J. (1994). Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
35. Adenoviral vectors damage normal arteries: use cautioned. (1996). Gene Therapy Weekly, March 4, 2-3.
36. Noguchi, P. (1994). As an oral presentation “FDA perspectives on gene therapy, " CHI symposium: “Gene Therapy, New Techniques and Applications.” April 25-27, Bethesda, MD.
37. Fox, J. L. (1993). NIHRAC and FDA ponder gene-therapy risks. Bio/Technology 11, 28-29.
38. Yang, N.S. (1992). Gene transfer into mammalian somatic cells in vivo, in “CRC Critical Reviews in Biotechnology.” Toronto, CRC Press, 335-356.
39. Nabel, G.J., Nabel, E.G., Yang, Z.Y., Fo, B.A., Plautz, G.E., Gao, X., Huang, L. Shu, S., Gordon, D., and Chang, A.E. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90, 11307-11311.
40. Yang, N.S., Burkholder, J., Roberts, B., Martinell, B., and McCabe, D. (1990). In vivo and In vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl. Acad. Sci. USA 87, 9568-9572.
41. Thompson, T. A., Gould, M. N., Burkholder, J. K., and Yang, N.S. (1993). Transient promoter activity in primary rat mammary epithelial cells evaluated using particle bombardment gene transfer. In Vitro Cell Dev. Biol. 29A, 165-170.
42. Guo, Z., Jiao, S. S., Cheng, L., Wolff, J., Yang, N. S., and Duncan, I. (1996). Efficient gene transfer and expression in mature rat oligodendrocytes in culture. J. Neuroscience Research, 43, 32-41.
43. Kusaka, S., Turner, J., Burlington, W., and Yang, N. S. (1996). Characteristics of in vivo expression of HLA transgenes in human skin grafts on SCID mouse. Submitted.
44. Cheng, L., Sun, J., Pretlow, T., and Yang, N. S. (1996). CWR22 xenograft as an ex-vivo human tumor model for prostate cancer gene therapy. J. Natl. Cancer Inst., 88, 607-611.
45. Mahvi, D. M., Burkholder, J. K., Turner, J., Malter, J., Sondel P., and Yang, N.S. (1996). Particlemediated gene transfer of GM-CSF cDNA to tumor cells: Implications for a clinically relevant tumor vaccine. Human Gene Therapy 7, 1535-1543.
46. Rajagopalan, L. E., Burkholder, J. K., Turner, J., Culp, J., Yang, N.-S., and Malter, J. (1995). Targeted mutagenesis of GM-CSF cDNA increases transgenic mRNA stability and protein expression in normal cells. Blood, 86, 2551-2558.
47. Rakhmilevich, A., Turner, J., Ford, M., McCabe, D., Wenn, S. H., Sondel, P. M., Grota, K., and Yang, N. S. (1996). Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. Proc. Natl. Acad. Sci. USA, 93, 6291-6296.
48. Cheng, L., Ziegelhoffer, P., and Yang, N.S. (1993). I n vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA 90, 4455-4459.
49. Williams, R.S., Johnson, S.A., Riedy, M., DeVit, M.J., McElligot, S.G., and Sanford, J.C. (1991). Introduction of foreign genes into tissues of living mice by DNA-coated Microprojectiles. Proc. Natl. Acad. Sci. USA 88, 2726-2730.
50. Sun, W. H., Burkholder, J. K., Sun, J., Decker, J., Turner J. G., Lu, X.G., Pugh, T.D., Ershler, W.B., and Yang, N.S. (1995). In vivo cytokine gene transfer by particle bombardment reduces tumor growth in mice. Proc. Natl. Acad. Sci. USA 87, 9568-9572.
51. Branda, M., Luistro, L., Warner, R., Wright, R., Hubbard, B., Murphy, M., Wolf, S., and Gately, M. (1993). Antitumor and Antimetastatic Activity of Interleukin 12 against Murine Tumors. J Exp. Med. 178, 1223-1230.
52. Nastala, C., Edington, H., McKinney, T., Tahara, H., Nalesnik, M., Brunda, M., Gately, M., Wolf, S., Schreiber, R., Storkus, W., and Lotze, M. (1994). Recombinant IL-12 Administration Induces Tumor Regression in Association with IFN-γ Production. J Immunology 153, 1697-1706.
53. Orange, J., Salazar-Mather, T., Opal, S., Spencer, R., Miller, A., McEwen, B., and Biron, C. (1995). Mechanism of Interleukin 12-mediated Toxicities during Experimental Viral Infections: Role of Tumor Necrosis Factor and Glucocorticoids. J. Exp. Med. 181, 901-914.
54. Jiao, S., Cheng, L., Wolff, J. A., and Yang, N.S. (1993). Particle bombardment-mediated gene transfer and expression in rat brain tissues. Bio/Technology 11, 497-502.
55. Burkholder, J. K., Decker, J., and Yang, N.S. (1993). Rapid transgene expression in lymphocyte and macrophage primary cultures after particle bombardment-mediated gene transfer. J. Immunol. Meth. 165, 149-156.
56. Ye, Z. Q., Qiu, P., Burkholder, J. K., Turner, J., Culp, J., Roberts, T., Shahidi, N. T., and Yang, N.S. (1996). Particle-mediated gene transfer into CD34+ hematopoietic progenitor cells from human umbilical cord blood. Submitted.